The secondary offering by major shareholders (Blackstone, Carlyle, Hellman & Friedman, GIC, ADIA) represents a significant monetization event, but the concurrent $200M repurchase partially offsets the overhang. Monitor the offering close and any subsequent insider selling patterns for further signals.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 19 $37.84entry
- T+1 · 2d ago −2.11%α +1.53% · $37.04
- T+5 · in 5d Pending
- T+20 · in 26d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Medline Inc. disclosed the pricing of a secondary offering of 60 million shares of Class A common stock by selling stockholders at $35.50 per share, expected to net approximately $2.1 billion for the sellers. Concurrently, Medline and Medline Holdings entered into a $200 million share and unit repurchase agreement with the same selling stockholders, repurchasing Class A common stock and Common Units at the offering price. The repurchase is conditioned on the offering's closing, which is expected on November 23, 2026.
Key Facts
- Secondary offering of 60,000,000 shares of Class A common stock at $35.50 per share
- Expected net proceeds to selling stockholders of approximately $2.1 billion
- Underwriters have a 30-day option to purchase up to an additional 9,000,000 shares
- Medline and Medline Holdings agreed to repurchase $200 million of Class A common stock and Common Units from selling stockholders
- Repurchase price equals the per share price paid by underwriters in the secondary offering
- Repurchase is conditioned on closing of the secondary offering; offering is not conditioned on the repurchase
- Repurchase counts toward Medline's previously announced share repurchase program
- Medline is not selling any shares and will not receive any proceeds from the offering
- Offering expected to close on November 23, 2026
Financial Impact
Selling stockholders to receive ~$2.1B in net proceeds from the secondary offering; Medline to repurchase $200M of equity interests at the same price, reducing shares outstanding by approximately 5.6 million shares (based on $35.50 per share).
Risk Factors
- Secondary offering of 60M shares (plus up to 9M option shares) creates near-term overhang, though the $200M repurchase partially offsets
- Selling stockholders include entities affiliated with Blackstone, Carlyle, Hellman & Friedman, GIC, and ADIA, all of whom (except ADIA) beneficially own more than 5% of Class A common stock
- Repurchase is conditioned on the offering closing; if the offering fails to close, the repurchase will not occur
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-467193 |
| Document: mdln-20261116.htm | 0001193125-26-467193 |
| Document: mdln-ex99_1.htm | 0001193125-26-467193 |
| Document: 0001193125-26-467193-index-headers.html | 0001193125-26-467193 |
| Document: 0001193125-26-467193-index.html | 0001193125-26-467193 |
| Document: 0001193125-26-467193.txt | 0001193125-26-467193 |
Track record
34 reports on MDLN
5 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +17.95% at T+20 after the May 6, 2026 report. 7 of 10 went positive at some point.
Filters
- Nov 19, 20262d ago 424B4 Bearish 5/10 Entry $39.04 Now $37.04 +5.12% settles Nov 30
- Nov 18, 20263d ago 8-K Neutral 4/10 Viewing Entry $37.84 Now $37.04 −2.11% settles Nov 27
- Nov 18, 20264d ago EFFECT Neutral 5/10 Entry $39.16 Now $37.04 −5.41% settles Nov 25
- Nov 17, 20264d ago Press Release Bearish 5/10 Entry $39.16 Now $37.04 +5.41% settles Nov 25
- Nov 16, 20266d ago Press Release Bearish 5/10 Entry $39.17 Now $37.04 +5.44% settles Nov 23
- Nov 16, 20266d ago S-1 Neutral 4/10 Entry $39.17 Now $37.04 −5.44% settles Nov 23
- Nov 13, 20268d ago SC 13G Neutral 3/10 Entry $39.17 Now $37.04 −5.44% settles Nov 23
- Nov 13, 20268d ago 144 Neutral 2/10 Entry $39.17 Now $37.04 −5.44% settles Nov 23
- Nov 6, 202615d ago SC 13G/A Neutral 3/10 Entry $40.71 to $39.17 Now $37.04 −9.01% ▼ −3.78% −2.09% vs SPY
- Nov 4, 202618d ago 8-K Neutral 5/10 No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers